Berger, I. et al. : [68Ga-PSMA PET/CT vs. mpMRI for locoregional prostate cancer staging : correlation with final histopathology. Prostate Cancer Prostatic Dis. 21 : 20 4-211, 2018.
Grubmüller, B. et al. : PSMA ligand PET/MRI for primary prostate cancer : staging performance and clinical impact. Clin. Cancer Res. 24 : 6300-6307, 2018.